Literature DB >> 32820593

Clinical and genetic characteristics of 10 Japanese patients with PROM1-associated retinal disorder: A report of the phenotype spectrum and a literature review in the Japanese population.

Kaoru Fujinami1,2,3,4, Akio Oishi5, Lizhu Yang1,2, Gavin Arno1,3,4,6, Nikolas Pontikos1,3,4, Kazutoshi Yoshitake7, Yu Fujinami-Yokokawa1,3,8,9, Xiao Liu1,2,10, Takaaki Hayashi11, Satoshi Katagiri11, Kei Mizobuchi11, Atsushi Mizota12, Kei Shinoda12,13, Natsuko Nakamura1,12,14, Toshihide Kurihara2, Kazuo Tsubota2, Yozo Miyake1,15,16, Takeshi Iwata7, Akitaka Tsujikawa5, Kazushige Tsunoda1.   

Abstract

Variants in the PROM1 gene are associated with cone (-rod) dystrophy, macular dystrophy, and other phenotypes. We describe the clinical and genetic characteristics of 10 patients from eight Japanese families with PROM1-associated retinal disorder (PROM1-RD) in a nationwide cohort. A literature review of PROM1-RD in the Japanese population was also performed. The median age at onset/examination of 10 patients was 31.0 (range, 10-45)/44.5 (22-73) years. All 10 patients showed atrophic macular changes. Seven patients (70.0%) had spared fovea to various degrees, approximately half of whom had maintained visual acuity. Generalized cone (-rod) dysfunction was demonstrated in all nine subjects with available electrophysiological data. Three PROM1 variants were identified in this study: one recurrent disease-causing variant (p.Arg373Cys), one novel putative disease-causing variant (p.Cys112Arg), and one novel variant of uncertain significance (VUS; p.Gly53Asp). Characteristic features of macular atrophy with generalized cone-dominated retinal dysfunction were shared among all 10 subjects with PROM1-RD, and the presence of foveal sparing was crucial in maintaining visual acuity. Together with the three previously reported variants [p.R373C, c.1551+1G>A (pathogenic), p.Asn580His (likely benign)] in the literature of Japanese patients, one prevalent missense variant (p.Arg373Cys, 6/9 families, 66.7%) detected in multiple studies was determined in the Japanese population, which was also frequently detected in the European population.
© 2020 The Authors. American Journal of Medical Genetics Part C: Seminars in Medical Genetics published by Wiley Periodicals LLC.

Entities:  

Keywords:  PROM1; autosomal dominant; cone dystrophy; cone rod dystrophy; macular dystrophy

Mesh:

Substances:

Year:  2020        PMID: 32820593     DOI: 10.1002/ajmg.c.31826

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  10 in total

1.  Genetic and Phenotypic Landscape of PRPH2-Associated Retinal Dystrophy in Japan.

Authors:  Akio Oishi; Kaoru Fujinami; Go Mawatari; Nobuhisa Naoi; Yasuhiro Ikeda; Shinji Ueno; Kazuki Kuniyoshi; Takaaki Hayashi; Hiroyuki Kondo; Atsushi Mizota; Kei Shinoda; Sentaro Kusuhara; Makoto Nakamura; Takeshi Iwata; Akitaka Tsujikawa; Kazushige Tsunoda
Journal:  Genes (Basel)       Date:  2021-11-18       Impact factor: 4.096

2.  Characterization of PROM1 p.Arg373Cys Variant in a Cohort of Chinese Patients: Macular Dystrophy Plus Peripheral Bone-Spicule Degeneration.

Authors:  Yingwei Wang; Panfeng Wang; Shiqiang Li; Jiamin Ouyang; Xiaoyun Jia; Xueshan Xiao; Junxing Yang; Xueqing Li; Wenmin Sun; Qingjiong Zhang
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-05-03       Impact factor: 4.799

3.  Development and validation of a visual field cluster in retinitis pigmentosa.

Authors:  Takashi Omoto; Akio Oishi; Ryo Asaoka; Yuri Fujino; Hiroshi Murata; Keiko Azuma; Manabu Miyata; Ryo Obata; Tatsuya Inoue
Journal:  Sci Rep       Date:  2021-05-06       Impact factor: 4.379

4.  ROP18-Mediated Transcriptional Reprogramming of HEK293T Cell Reveals New Roles of ROP18 in the Interplay Between Toxoplasma gondii and the Host Cell.

Authors:  Jie-Xi Li; Jun-Jun He; Hany M Elsheikha; Jun Ma; Xiao-Pei Xu; Xing-Quan Zhu
Journal:  Front Cell Infect Microbiol       Date:  2020-11-30       Impact factor: 5.293

5.  Visual Field Characteristics in East Asian Patients With Occult Macular Dystrophy (Miyake Disease): EAOMD Report No. 3.

Authors:  Seong Joon Ahn; Lizhu Yang; Kazushige Tsunoda; Mineo Kondo; Yu Fujinami-Yokokawa; Natsuko Nakamura; Takeshi Iwata; Min Seok Kim; Yongseok Mun; Jun Young Park; Kwangsic Joo; Kyu Hyung Park; Yozo Miyake; Ruifang Sui; Kaoru Fujinami; Se Joon Woo
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-01-03       Impact factor: 4.799

6.  Association between the number of visual fields and the accuracy of future prediction in eyes with retinitis pigmentosa.

Authors:  Ryo Asaoka; Akio Oishi; Yuri Fujino; Hiroshi Murata; Keiko Azuma; Manabu Miyata; Ryo Obata; Tatsuya Inoue
Journal:  BMJ Open Ophthalmol       Date:  2021-11-18

7.  Detecting Progression of Retinitis Pigmentosa Using the Binomial Pointwise Linear Regression Method.

Authors:  Shotaro Asano; Akio Oishi; Ryo Asaoka; Yuri Fujino; Hiroshi Murata; Keiko Azuma; Manabu Miyata; Ryo Obata; Tatsuya Inoue
Journal:  Transl Vis Sci Technol       Date:  2021-11-01       Impact factor: 3.283

8.  Genomics and morphometrics reveal the adaptive evolution of pikas.

Authors:  Rui-Xiang Tang; Jiao Wang; Yi-Fei Li; Cheng-Ran Zhou; Guan-Liang Meng; Feng-Jun Li; Yue Lan; Megan Price; Lars Podsiadlowski; Yan Yu; Xu-Ming Wang; Yin-Xun Liu; Bi-Song Yue; Shan-Lin Liu; Zhen-Xin Fan; Shao-Ying Liu
Journal:  Zool Res       Date:  2022-09-18

9.  Dominant Cone Rod Dystrophy, Previously Assigned to a Missense Variant in RIMS1, Is Fully Explained by Co-Inheritance of a Dominant Allele of PROM1.

Authors:  Maria Pilar Martin-Gutierrez; Elena R Schiff; Genevieve Wright; Naushin Waseem; Omar A Mahroo; Michel Michaelides; Anthony T Moore; Andrew R Webster; Gavin Arno
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-08-02       Impact factor: 4.925

10.  Introduction to the special issue on Ophthalmic Genetics: Vision in 2020.

Authors:  Robert B Hufnagel; Michael A Walter; Gavin Arno
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-08-31       Impact factor: 3.359

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.